A customizable dosing system is provided, comprising an anticholinergic, central nervous system stimulant such as caffeine with other ingredient. It"s specifically used for nausea, vomiting, and dizziness associated with vertigo in diseases particularly morning sickness in pregnant women.

The present invention describes of a synergistic oral composition comprising of taurine and racemethionine, wherein the taurine being taken in the range of 250mg to 500mg and the racemethionine is taken in the range of 100mg to 200mg by weight of the composition, the active weight resulting into a therapeutically , sy...

This invention is based on an oral formulation which comprises two or more active ingredients along with some pharmaceutically excipients acceptable for the treatment of hepatic diseases and provide antioxidant, antitoxic properties along with osmoregulatory effects.

This invention is based on an efficient treatment of diabetic neurotharapy the drug combination is made up three ingredients. These are taurine, folic acid and methylcobalamin. These are working as a synergistic compound for the treatment of diabetic neurotharapy .the concentration of these compounds are Methylcobal...

The present invention related to a synergistic pharmaceutical composition which contains more than one active ingredients which are diclofenac, glycofurol and Drotaverine with pharmaceutically accepted excipients. The present stable and effective combined composition shows enhanced efficacy and synergistic effect to...

The invention relates to a novel combination pharmaceutical formulation of an active antipyretic and analgesic which is paracetamol and other pharmaceutical excipeients for example glycofurol, hydroxylpropylbetadextrin thereof and a method for preparation of said formulation.

This invention is based on a synergistic combination of hepetoprotective agents which consists of Nimesulide, Cysteine and Glutathione. These works against hepatotoxin like Pyrrolidine alkaloids, Luteoskyrin,Aflatoxin,Carbon tetrachloride thereof. These compounds have Hepatoprotection activity. Hepatoprotection activi...

This invention is based on an exclusive pharmaceutical formulation to reduce inflammation bones and joint friction with improve cartilage quality, these ingredients are Glucosamine, MSM (Methyl Suphonil Methane), Taurine and Racemethionin.the concentration of following ingredients are Glucosamine is 500mg/ capsule,Met...

The disclosure relates to efficient pharmaceutical combination for the treatment of bone and women related diseases. It resolves all the complications which normally woman faces during pregnancy, menopause and post menopause along with osteoporosis thereof.

The present invention disclosed sustained release bilayer paracetamol oral formulation. A two layer paracetamol tablet is available in which one layer is comprised of quick release paracetamol granules and the other layer is comprised of sustained release paracetamol which is release after some time. The Initial dos...

The present invention provides a pharmaceutical product comprising, in combination of, (a) a (therapeutically effective) dose of a first active ingredient acebrophyllin or a pharmaceutically acceptable salt thereof; and (b) a (therapeutically effective) dose of a second active ingredient cetirizine The invention furth...

The present invention relates to Pharmaceutical compositions for the treatment of alcoholism which is containing taurine and race-methionine. Taurine can either promote or repress the reward effects associated with alcohol; the delineating factor being the amount of alcohol consumed its role in alcoholism. Its major...

This invention is based on efficacy of compounds and combination of compounds. Which essential for treatment of a number of diseases. These are pain, antiinfilamation, hepatoprotective, fever, allergy thereof. This combination has less toxicity, it has highly hepatotoxicity. The main mechanism of action of paracetam...

An oral pharmaceutical composition which contains an active ingredients which is Ambroxol. levo cetrizine, Ketotifen together with one or more physiologically acceptable excipients. The present invention describes process for preparation of active ingredients with pharmaceutical acceptable excipients. The compositions...

Disclosed herein this invention provides energy vitaliser provider oral composition with different release profile such as Sustained or controlled or retard formulation in various form such as capsule, tablet, powder and in liquid thereof for those individuals which are unable to get high energy easily such as non-bre...

This invention is based on a potent revital formulation which comprises two or more active ingredients along with some pharmaceutically acceptable excipients preferably in oral dosage form.

This invention is based on a oral formulation which comprises two or more active ingredients along with some pharmaceutically acceptable excipients for the treatment of hepatic diseases, Osteoarthritis, cardiovascular and neurological disorder thereof.

The present invention is based on muscle relaxant medicament dosage containing a combination of a non steroidal anti inflammatory drug and a thiocolchicoside derivative.

This invention is based on strong antioxidants which are useful for all age group. The basic composition of ingredients are-EPA 150 mg, DHA 100 mg, Folic Acid 5 mg and Lycopene 50 mg. DHA is a major fatty acid in sperm and brain phospholipids, particularly in the retina. Dietary DHA may reduce the risk of heart dise...